Postbiotic anticancer validation from fermented soybean tempeh using MTT assay
Research platform validating anticancer activity of postbiotics derived from tempeh, a traditional Indonesian fermented soy product. Using MTT cell viability assays, this work differentiates bioactive effects of fermented versus non-fermented soybeans, targeting gut microbiome modulation and cytotoxicity against cancer cell lines.
Overview
This research program investigates the anticancer potential of postbiotics generated through fermentation of soybeans into tempeh, a traditional Indonesian food. The core hypothesis is that bioactive compounds produced during fermentation can inhibit cancer cell activity, partly by modulating the gut microbiota toward a healthier profile that supports beneficial organisms such as Bifidobacterium and Akkermansia muciniphila. By comparing fermented tempeh against non-fermented soybeans, the project aims to establish a scientific basis for functional health benefits of postbiotics and identify candidate bioactive fractions for further development in nutraceutical, functional food, and adjunctive therapeutic applications.
Technical specifications
Research approach:
- Tempeh is produced through controlled fermentation, then freeze-dried and ground into powder for laboratory testing
- MTT assay (a colorimetric method that measures cellular metabolic activity) is used to evaluate cell viability, proliferation, and cytotoxicity
- Comparative testing between fermented soybean (tempeh) and non-fermented soybean controls isolates the contribution of fermentation-derived postbiotics
- Future work includes profiling water activity, protein content, and fat content of tempeh versus non-fermented soybeans to characterize the bioactive matrix
- Expanded validation across multiple cancer cell lines is planned to determine breadth of postbiotic functionality
Key features:
- Focus on postbiotics, which are beneficial compounds produced by probiotic microorganisms, offering advantages over live bacteria including improved stability and safety
- Established, widely accepted MTT assay methodology for cytotoxicity screening
- Differentiation between whole fermented food effects and isolated bioactive components
Technology readiness level
The research is at an early experimental stage. Tempeh production and freeze-drying protocols are established, and initial MTT assay procedures have been defined. Validation work is ongoing, with planned expansion to include compositional characterization (water activity, protein, fat) and broader cancer cell line screening. The program is positioned for partnership to accelerate characterization, scale bioactive fraction identification, and advance toward potential nutraceutical or functional food product development.
About University of Maryland
The University of Maryland is the state's flagship public research university in College Park, serving a large student body and offering comprehensive academic and research programs. Industry engages through an adjacent research park, shared prototyping facilities, and dedicated corporate partnership channels, plus joint pathways to a medical campus for clinical and regulatory engagement. Its Washington–Baltimore location places partners near federal agencies, national labs, and prime contractors, while a statewide extension network supports collaboration with companies. Research is backed by competitive federal funding from agencies such as NSF, NIH, DoD, DOE, NASA, and USDA, and coordinated commercialization services advance IP, startup formation, licensing, and industry-sponsored research.
delivered to your inbox.